Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

120.54 

0.91 0.8%

as of Jun 19 '19

52 Week Range:

90.64 121.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Equity (BVPS) 7.12
7.41
8.51
11.41
11.33
12.45
12.05
10.94
11.90
13.05
14.49
growth rate 4.1% 14.8% 34.1% -0.7% 9.9% -3.2% -9.2% 8.8% 9.7% 11.0%
Earnings BIT 157.86
201.68
260.59
303.71
331.95
385.12
411.41
409.24
435.87
456.73
560.26
growth rate 27.8% 29.2% 16.6% 9.3% 16.0% 6.8% -0.5% 6.5% 4.8% 22.7%
Avg.PE 25.51
21.46
24.81
21.41
18.28
21.51
21.19
22.22
28.05
32.93
49.24
growth rate -15.9% 15.6% -13.7% -14.6% 17.7% -1.5% 4.9% 26.2% 17.4% 49.5%
ROA 8.30
10.05
12.13
12.29
12.12
14.13
15.10
15.53
12.95
10.18
9.66
growth rate 21.1% 20.7% 1.3% -1.4% 16.6% 6.9% 2.9% -16.6% -21.4% -5.1%
ROE 10.96
13.33
15.82
15.04
15.27
19.09
20.50
21.10
21.47
18.73
15.70
growth rate 21.6% 18.7% -4.9% 1.5% 25.0% 7.4% 2.9% 1.8% -12.8% -16.2%
ROIC 9.73
11.73
14.67
13.59
12.60
14.92
16.38
17.04
13.76
12.53
11.98
growth rate 20.6% 25.1% -7.4% -7.3% 18.4% 9.8% 4.0% -19.3% -8.9% -4.4%
Cur. Ratio 3.84
3.17
3.15
6.19
5.38
2.52
5.77
5.40
2.22
4.57
2.08
growth rate -17.5% -0.6% 96.5% -13.1% -53.2% 129.0% -6.4% -58.9% 105.9% -54.5%
Quick Ratio 2.75
2.34
2.31
4.88
4.33
2.10
4.75
4.04
1.74
3.53
1.32
growth rate -14.9% -1.3% 111.3% -11.3% -51.5% 126.2% -15.0% -56.9% 102.9% -62.6%
Leverage 1.30
1.35
1.26
1.20
1.33
1.37
1.34
1.38
1.92
1.77
1.49
growth rate 3.9% -6.7% -4.8% 10.8% 3.0% -2.2% 3.0% 39.1% -7.8% -15.8%
Balance Sheet Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Acct.Receivable 192.20
212.10
226.90
274.40
305.03
365.81
359.59
362.57
382.09
450.53
483.68
growth rate 10.4% 7.0% 20.9% 11.2% 19.9% -1.7% 0.8% 5.4% 17.9% 7.4%
Acct.Payable 211.24
229.08
85.41
81.11
92.57
92.76
92.72
growth rate 8.5% -62.7% -5.0% 14.1% 0.2% 0.0%
Cur.Assets 739.20
853.30
985.30
1,292.50
1,361.15
1,448.85
1,556.21
1,407.84
1,419.72
1,644.00
1,065.72
growth rate 15.4% 15.5% 31.2% 5.3% 6.4% 7.4% -9.5% 0.8% 15.8% -35.2%
Total Assets 1,406.00
1,508.00
1,626.40
2,068.90
2,137.87
2,210.72
2,360.96
2,181.77
3,256.71
3,468.49
3,063.92
growth rate 7.3% 7.9% 27.2% 3.3% 3.4% 6.8% -7.6% 49.3% 6.5% -11.7%
Cash 321.08
415.70
488.80
735.30
809.54
876.05
905.73
717.25
731.43
821.94
188.70
growth rate 29.5% 17.6% 50.4% 10.1% 8.2% 3.4% -20.8% 2.0% 12.4% -77.0%
Inventory 158.25
157.40
185.60
200.80
174.35
145.85
165.42
246.86
224.46
268.32
268.70
growth rate -0.5% 17.9% 8.2% -13.2% -16.4% 13.4% 49.2% -9.1% 19.5% 0.1%
Cur.Liabilities 192.60
269.10
312.70
208.80
252.85
574.05
269.56
266.46
637.99
360.13
511.25
growth rate 39.7% 16.2% -33.2% 21.1% 127.0% -53.0% -1.2% 139.4% -43.6% 42.0%
Liabilities 324.20
392.80
338.90
338.20
530.24
600.21
602.71
594.47
1,561.87
1,508.22
1,004.94
growth rate 21.2% -13.7% -0.2% 56.8% 13.2% 0.4% -1.4% 162.7% -3.4% -33.4%
LT Debt 93.79
94.20
0.00
100.00
250.78
0.77
300.77
300.59
873.33
1,078.61
269.99
growth rate 0.4% -100.0% 150.8% -99.7% 39,011.8% -0.1% 190.5% 23.5% -75.0%
Equity 1,081.80
1,115.20
1,287.50
1,730.70
1,607.63
1,610.52
1,758.25
1,587.31
1,694.83
1,960.27
2,058.98
growth rate 3.1% 15.5% 34.4% -7.1% 0.2% 9.2% -9.7% 6.8% 15.7% 5.0%
Common Shares 157.00
154.00
155.00
157.00
149.00
146.00
144.00
143.00
142.00
142.00
144.00
growth rate -1.9% 0.7% 1.3% -5.1% -2.0% -1.4% -0.7% -0.7% 0.0% 1.4%
Cash Flow Statement Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Capital Expenditures 81.42
107.90
56.90
66.60
47.14
63.58
72.72
62.50
58.53
62.22
62.58
growth rate 32.5% -47.3% 17.1% -29.2% 34.9% 14.4% -14.1% -6.4% 6.3% 0.6%
Cash Dividends 0.00
0.00
0.00
0.00
0.00
97.20
141.52
157.26
168.13
186.35
199.50
growth rate 45.6% 11.1% 6.9% 10.8% 7.1%
Cash From OA 137.84
238.90
188.20
283.20
383.16
402.82
391.27
383.18
547.93
414.05
505.03
growth rate 73.3% -21.2% 50.5% 35.3% 5.1% -2.9% -2.1% 43.0% -24.4% 22.0%
FCF per Share 0.39
0.81
0.82
1.32
1.92
2.11
2.21
2.24
3.00
2.45
3.08
growth rate 107.7% 1.2% 61.0% 45.5% 9.9% 4.7% 1.4% 33.9% -18.3% 25.7%
Sale Purchase of Stock -330.25
-117.02
33.35
38.81
27.69
30.16
23.33
growth rate 0.0% 100.0% 16.4% -28.6% 8.9% -22.6%
FCF 62.00
125.00
127.00
208.00
322.00
331.00
310.00
311.00
480.00
343.00
434.00
growth rate 101.6% 1.6% 63.8% 54.8% 2.8% -6.3% 0.3% 54.3% -28.5% 26.5%
Income Statement Jun '08 Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Sales 835.40
920.70
1,092.40
1,243.10
1,368.52
1,514.46
1,554.97
1,678.91
1,838.71
2,066.74
2,340.20
growth rate 10.2% 18.7% 13.8% 10.1% 10.7% 2.7% 8.0% 9.5% 12.4% 13.2%
Op.Income 143.00
190.30
240.40
266.90
254.85
307.13
411.41
409.24
435.87
456.73
560.26
growth rate 33.1% 26.3% 11.0% -4.5% 20.5% 34.0% -0.5% 6.5% 4.8% 22.7%
IBT 157.86
201.70
260.60
303.70
331.95
385.12
431.08
435.92
439.57
418.74
521.31
growth rate 27.8% 29.2% 16.5% 9.3% 16.0% 11.9% 1.1% 0.8% -4.7% 24.5%
Net Income 110.30
146.40
190.10
227.00
254.85
307.13
345.27
352.89
352.41
342.28
315.59
growth rate 32.7% 29.9% 19.4% 12.3% 20.5% 12.4% 2.2% -0.1% -2.9% -7.8%
EPS 0.70
0.95
1.23
1.44
1.71
2.10
2.39
2.47
2.49
2.40
2.19
growth rate 35.7% 29.5% 17.1% 18.8% 22.8% 13.8% 3.4% 0.8% -3.6% -8.8%
Gross Profit 493.80
553.80
655.50
741.30
820.74
940.66
989.79
1,011.40
1,066.50
1,201.75
1,362.16
growth rate 12.2% 18.4% 13.1% 10.7% 14.6% 5.2% 2.2% 5.5% 12.7% 13.4%
R&D 63.10
75.20
92.00
109.73
144.89
118.23
114.87
118.65
144.47
155.15
growth rate 19.2% 22.3% 19.3% 32.0% -18.4% -2.8% 3.3% 21.8% 7.4%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 147.30
154.39
144.13
163.20
156.98
growth rate 4.8% -6.7% 13.2% -3.8%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 498.43
483.68
476.60
490.82
521.85
growth rate -3.0% -1.5% 3.0% 6.3%
Acct.Payable 88.16
92.72
98.71
110.34
124.47
growth rate 5.2% 6.5% 11.8% 12.8%
Cur.Assets 1,604.41
1,065.72
1,088.24
1,063.54
1,102.70
growth rate -33.6% 2.1% -2.3% 3.7%
Total Assets 3,534.21
3,063.92
3,067.54
3,859.82
4,098.53
growth rate -13.3% 0.1% 25.8% 6.2%
Cash 704.28
188.70
230.19
149.47
146.51
growth rate -73.2% 22.0% -35.1% -2.0%
Inventory 288.70
268.70
282.56
296.51
319.93
growth rate -6.9% 5.2% 4.9% 7.9%
Cur.Liabilities 461.46
511.25
421.11
436.44
462.97
growth rate 10.8% -17.6% 3.6% 6.1%
Liabilities 1,467.24
1,004.94
1,167.28
1,903.77
2,077.20
growth rate -31.5% 16.2% 63.1% 9.1%
LT Debt 810.00
269.99
517.64
1,185.50
1,323.35
growth rate -66.7% 91.7% 129.0% 11.6%
Equity 2,066.96
2,058.98
1,900.26
1,956.04
2,021.33
growth rate -0.4% -7.7% 2.9% 3.3%
Common Shares 0.57
0.57
0.57
0.57
0.57
growth rate 0.0% -0.2% 0.5% 0.0%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Capital Expenditures 12.96
17.62
12.99
18.43
15.08
growth rate 36.0% -26.3% 41.8% -18.2%
Cash Dividends 49.97
49.97
52.79
52.77
53.03
growth rate 0.0% 5.7% 0.0% 0.5%
Cash From OA 149.08
129.42
48.12
129.47
139.65
growth rate -13.2% -62.8% 169.1% 7.9%
Sale Purchase of Stock 3.02
13.73
growth rate 355.2%
FCF 136.12
111.80
35.13
111.04
124.56
growth rate -17.9% -68.6% 216.1% 12.2%
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 591.63
623.63
588.28
651.10
662.23
growth rate 5.4% -5.7% 10.7% 1.7%
Op.Income 147.30
154.39
144.13
163.20
156.98
growth rate 4.8% -6.7% 13.2% -3.8%
IBT 130.14
140.92
138.88
146.27
137.93
growth rate 8.3% -1.5% 5.3% -5.7%
Net Income 110.13
109.81
105.74
124.64
105.42
growth rate -0.3% -3.7% 17.9% -15.4%
EPS
growth rate
Gross Profit 344.30
362.47
343.09
383.73
391.91
growth rate 5.3% -5.4% 11.8% 2.1%
R&D 37.43
39.66
38.79
43.11
47.61
growth rate 5.9% -2.2% 11.1% 10.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (59.76)

YOY Growth Grade:

C (54.55)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 36.48 38.65 28.89
EPS / Growth 6.5% 3.12 9.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.0% 7.2% 7.2%
Future PE 11.96 26.59 26.59
Future EPS 5.58 6.25 6.25
Value Price
MOS %
16.48
-86.3%
41.09
-65.9%
41.09
-65.9%
MOS Price 8.24 20.54 20.54
IRT 19.92 18.40 18.40

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.